Lei Feng

5PUBLICATIONS
63CO-AUTHORS
Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 09, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

|Dec 03, 2025
Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.

Karan L Chohan, Lorenzo Gensini, Sherif Seif

|Jul 29, 2025
A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.

Paolo Strati, Lei Feng, Andrey Tyshevich

|May 09, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.

Oren Pasvolsky, Danai Dima, Lei Feng

|Nov 13, 2023
Race, Ethnicity, and Sustained Opioid Use After Major Abdominal Surgery for Cancer.

Pascal Owusu-Agyemang, Lei Feng, Juan P Cata

Pageof 1

Frequent Collaborators

2 joint publications

Christopher R Flowers

2 joint publications

Oren Pasvolsky

2 joint publications

Sairah Ahmed

2 joint publications

Hans C Lee